SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001185185-18-001559
Filing Date
2018-08-24
Accepted
2018-08-24 09:03:39
Documents
2
Period of Report
2018-08-16
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K biostar20180824_8k.htm 8-K 21541
2 EXHIBIT 99.1 ex_122718.htm EX-99.1 7608
  Complete submission text file 0001185185-18-001559.txt   30382
Mailing Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046
Business Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046 011-86-29-33686638
Biostar Pharmaceuticals, Inc. (Filer) CIK: 0001418133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34708 | Film No.: 181035915
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1